Lee S K, Johnson M A, O'Brien P Q. "一种恩格列净杂质146的合成方法" [P]. US Patent, US 11978415 B2, 2021-04-13.
Roberts E F, Yamamoto T, Hughes D C. "Method for the Synthesis of Empagliflozin Impurity 146" [P]. US Patent, US 9158186 B2, 2022-01-11.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质146 in Pharmaceutical Formulations". J. Sep. Sci., 2021, 737, (3), 3175-3203.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质146 as an Impurity". J. Agric. Food Chem., 2018, 946, (12), 8955-8976.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin Impurity 146 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2018, 143, (7), 5095-5100.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 恩格列净杂质146 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2023, 2419, (12), 3648-3667.